The goal of thisarticle isto review a series ofpatientswith persistent unilateral middle ear effusion (MEE) and to suggest a more contemporary diagnostic algorithm. The author conducted a retrospective chart review of adults with persistent unilateral MEE and normalfindings on physical and nasopharyngoscopic examinations whose MEE was eventually found to be caused by a variety of occult skullbase lesions. The studypopulation wasmade up of 79 patients-52 women and 27 men, aged 21 to 83 (mean: 54.8) at presentation-who had been referred to an academic tertiarycare medical center between July 1, 1988, andJune 30,2008. Follow-up rangedfrom 9 months to 19.5 years (mean: 8.7 yr). Of this group, 50 patients (63.3%) had a malignant tumor, 26 (32.9%) had a benign tumor, and 3 (3.8%) had an internal carotid artery aneurysm. Eustachian tubeocclusion had been caused by diffuse invasion in33patients (41.8%), byintracranialpathology in24 (30.4%), andbyextracrantal-infratemporal lesions in22 (27.8%). Nasopharyngoscopy cannotidentify a variety of rare skull base lesions that cause eustachian tubecompression or tissue invasion that ultimately leads to MEE. Therefore, patients with unexplained persistent unilateral MEE should undergo coronal magnetic resonance imaging or computed tomography to lookfor any intra-orextracraniallesions before undergoingventilation tubeplacement.
Introduction
Secretory otitis media is a common cause of aural fullness and hearing loss secondary to eustachian tube inflammation, edema, or obstruction.' Some cases of middle ear effusion (MEE) are self-limited while others require medical management in the form of a topical steroid nasal spray, an oral steroid, a decongestant, an antihistamine, an antibiotic, or allergy therapy-"
In addition to a complete head and neck examination, all patients who present with persistent unilateral MEE should undergo nasopharyngoscopy to look for congenital narrowing, acquired stenosis, or neoplastic obstruction of the eustachian tube orifice." When findings on both examinations are normal, many adult patients undergo additional medical management or ventilation tube insertion for presumed MEE induced by eustachian tube dysfunction." Although such a treatment strategy is safe and successful in patients with typical recurrent MEE, it might not detect occult skull base lesions that compress or invade the eustachian tube.'
In this article, the author describes his review of a series of MEE patients with occult skull base lesions.
Patients and methods
Upon obtaining Institutional Review Board approval, the author retrospectively reviewed the charts of 79 adults (~19 yr) with persistent unilateral MEE whose findings on initial head and neck examination and nasopharyngoscopy were normal. The 79 patients were made up of 52 womenand27men, aged 21 to 83 (mean: 54.8) at presentation.
All 79 patients had been referred to the author from communityotolaryngologists or primarycare physicians 5 to 51 months after their initial presentation (mean: 37.2). They were evaluated at the author's tertiary care academic medical center between July 1, 1988, and June 30, 2008.
All patients were subsequently found to have had an Tumor histology. Of the 50 malignant tumors, 20 were undifferentiated carcinomas that had likely originated in the submucosal lateral nasopharynx (figure 3). Twelve patients had a metastasis from the kidney, prostate, lung, or esophagus. The most common of the 26 benign tumors were trigeminal neuromas (figure 4, A) and meningiomas (figure 4, B).
Additional treatment. Of the 50 patients with a malignant tumor, 19 underwent wide-field skull base
Results
Presenting symptoms and signs. All 79 patients had complained of aural fullness and hearing loss. Other presenting otologic symptoms included tinnitus, otalgia, and dizziness (table 1) .
All patients had presented with serous MEE, and almost one-third of them demonstrated a pars tensa retraction. Other Figure 1 . Thisalgorithm provides a diagnostic and treatmentguidefor the treatpresenting signs included trismus, facial ment of adultswhodo not respond to themedical managementof unilateral MEE. hypoesthesia, cranial nerve VI palsy, and vocal fold paralysis (table 1) .
History. Ofthe 79 patients, 61 (77.2%)had undergone at least one myringotomy with ventilation tube insertion, which had delayed their diagnosis by a mean of more than 3 years; roughly half of these patients had undergone more than one such procedure. Only 23 of the 79 patients (29.1%)had undergone any radiographic studies prior to referral. Theseinvestigations included CT of the sinuses in 6 patients, CT of the temporal bones in 5, CT of the temporomandibular joint in 5, MRI of the head in 4, and a panoramic x-ray of the mandible in 3.
Site oforigin. Of the 79 previously undetected skull base lesions, 42 were located on the right and 37 on the left. The most common sites of origin were the infratemporal fossa and the middle cranial fossa. The site of origin could not be determined in 19 patients because ofthe extent of the lesion (table 2) .
Eustachian tube occlusion had been caused by diffuse invasion in 33 patients (41.8%),by intracranial pathology occult skull base lesion that was believed to have caused the MEE by obstructing or invading the eustachian tube. Follow-up ranged from 9 months to 19.5years (mean: 8.7 yr).
Between 1988 and 1996 at the author's institution, the diagnostic algorithm for unilateral MEEwith a normal head and neck examination included contrast-enhanced paranasal sinus computed tomography (CT). Since 1996, we have employed a paranasal sinus magnetic resonance imaging (MRI) series with and without contrast; in the past 6 years, we have minimized the MRI to only coronal sections with and without contrast. For patients who cannot undergo MRI, we obtain a coronal sinus CT. Our overall diagnostic algorithm is shown in figure 1. 
The Montreal Protocol brought an end to the dry spray
The problem with the dry sprays was their propellant-ehlorofluorocarbon (CFC). CFCs are known to be an ozone-depleting substance (ODS) and harmful to the environmenF The "Montreal Protocol on Substances that Deplete the Ozone Layer" is an important international environmental treaty under which the US agreed to phase out the production and importation ofODSs. An exception to this rule was medical products that were determined to be "medically essential."3 Many asthma and chronic obstructive pulmonary disease (CaPO) products fell into this category but nasal allergy sprays did not-and as of January 1, 1996, nonmedically essential products could no longer be manufactured. 2 ,4 Wet sprays attempted to fill the treatment void With dry formula sprays no longer an option, doctors sought other solutions for their patients. "You can only use what you have available," said Dr. Meltzer. "On apersonal level I preferred the aerosols, but they became less and less available, so we switched to the aqueous corticosteroid sprays, and they were "On a personal level I preferred the (dry) aerosols, but they became less and less available..." ELI MELTZER, MD effective." To this day, aqueous nasal sprays are a valuable treatment option for many patients. However, they are not without their issues.
NASAL stUdy revealed patient dissatisfaction
In 2010, a landmark survey of allergic rhinitis patients and their physicians was conducted to assess how well patients were being manaqed.' The National Allergy Survey Assessing Limitations (NASAL) revealed that many patients were dissatisfied with their current medication. Over 60% ofsurveyed patients who had used an INS spray in the past year reported that they experienced "medication drip back down the throat." Additionally, just over 18% of patients reported that they experienced "discomfort from spray." Nearly 1 in5 nasal allergy sufferers asked their doctor to change their INS spray. Of those patients, 28% cited "bothersome side effects" as the cause of their dissatisfaction.
Dry sprays make a welcome return
In time, researchers developed a new, III environmentally friendly aerosol propellant. 2 , This was welcome news for physicians like Dr. Meltzer: "We were very pleased when HFA (hydrofluoroalkane) asthma inhalers became available and we encouraged the pharmaceutical companies to develop them for nasal al lrgy treatment. It's nice to say that we now have acouple ofdry spray options. Iliked them when they were first available, I preferred them when I had access to both the aqueous and the aerosol, and I still prefer them today." Many patients may also agree. "There are patients who prefer one over the other, and it's important toindividualize treatment. Iconsider the . dry sprays for patients who have agreat amount ofnasal drainage orblockage, orfor patients who prefer something that doesn't have sensory attributes," said Dr. Meltzer. radiotherapy, and 30 received chemotherapy with radiotherapy; 1 patient refused additional treatment.
Sixteen of the 19 patients who underwent radiotherapy had a parotid gland malignancy, and the other 3 had an undifferentiated carcinoma. Of the 26 patients with a benign tumor, stereotactic radiotherapy was delivered to 2 who had a trigeminal neuroma and to 4 who had a subtotally resected meningioma. The remaining 20 patients underwent surgical resection or drainage alone.
All 3 patients with an internal carotid artery aneurysm were managed with cerebral angiography and endovascular stenting.
Outcomes. Thirty-four of the 50patients with a malignanttumor (68.0%) died of their disease, and 10(20.0%) were alivebut with active disease at study's end. None of the 26 patients with a benign tumor had died, and 17 of them (65.4%) had no evidence of disease. Likewise, all 3 patients with an aneurysm were alive and well after treatment ( these four locations, only the nasopharynx is accessible to physical examination. The initial evaluation of any patient with MEE begins with a complete history of symptoms, including the duration of aural fullness, similar episodes in the past, recent airplane travel or other causes of barotrauma, blunt temporal bone injury, sinus disease or surgery, radiotherapy to the head and neck, tobacco use, cleft palate, gastroesophageal reflux, or sinonasal allergic disease."
Following a complete history of symptoms and a systems review,patients with persistent unilateral MEE should undergo a thorough head and neck examination, with particular attention paid to cervical lymph node palpation, magnified otoscopy, bimanual parotid palpation, cranial nerve assessment, and nasopharyngoscopy. A finding of a nasopharyngeal mass, with or without cervical lymphadenopathy, warrants a biopsy of the mass, staging of the disease, and appropriate management.
When the history of a patient with unilateral MEE is unproductive and findings on physical examination are normal, most otolaryngologists initiate medical Table 3 . Diagnostic (biopsy) or treatment approach (N =79)
Discussion
Aural fullness secondary to MEE is most often associated with eustachian tube dysfunction.' Long-term eustachian tube failure may lead to negative middle ear p,ressure,tympanic membrane atelectasis, adhesive middle ear disease, or cholesteatoma," In the adult population, unilateral MEE may result from eustachian tube compression or invasion rather than from physiologic dysfunction. Gacek identified the four levels of potential eustachian tube compromise as being (l) the lumen of the eustachian tube, (2) the nasopharynx, (3) the infratemporal fossa, and (4) In conclusion, the evaluation of an adult with unilateral MEE has traditionally included the history, physical examination, and flexible fiberoptic nasopharyngoscopy. The present review describes 79 cases of intra-or extracraniallesions causing eustachian tube obstruction that were identified only by radiographic evaluation. It is therefore suggested that coronal MRI or CT with contrast be undertaken prior to ventilation management with a topical steroid nasal spray, an oral steroid, a decongestant, an antihistamine, an antibiotic, or allergy therapy.'" Ventilation tube placement is generally offered to patients with persistent MEE when medical management is unsuccessful. 10 All 79 patients in this study were initially assessed and managed in the above-described fashion. Aspreviously stated, 61 ofthese patients (77.2%) had undergone at least one ventilation tube insertion, which resulted in a mean delay in diagnosis of more than 3 years.
The clinical challenge for the physician who encounters unilateral MEE is to identify the small percentage of patients with persistent MEE secondary to eustachian tube invasion or compression by occult lesions of the middle cranial fossa, petrous apex, or infratemporal fossa. The diagnostic algorithm at our institution (figure 1) is offered as a solution in the hope that earlier identification of these unusual causes ofunilateral MEE may lead to improved treatment tube insertion in patients with persistent unilateral MEE and normal findings on physical examination and nasopharyngoscopy.
